| 中文名称 | 克罗米通 |
|---|---|
| 中文别名 | 克罗米通;N-乙基-邻巴豆酰甲基苯胺;优力肤;优力肤(克罗他米通);N-乙基-邻巴豆酰甲基苯胺,N-Ethyl-o-crotonotoluidide;克罗米通 EP标准品;克罗米通 USP标准品;克罗米通,BR;克罗米通,N-乙基-邻巴豆酰甲基苯胺;克罗米通标准品;克罗米通,医药级,纯度:>99% |
| 英文名称 | Crotamiton |
| 英文别名 | Crotamiton;BUT-2-ENOIC ACID ETHYL-2-TOLYLAMIDE;CROTAMITONUM;CROTONYL N-ETHYL-O-TOLUIDINE;N-ETHYL-2-CROTONYL METHYL ANILINE;n-ethyl-n-(2-methylphenyl)-butenamide;N-ETHYL-O-CROTONOTOLUIDE;N-ETHYL-O-CROTONOTOLUIDIDE;N-ETHYL-O-CROTONOTOLUIDINE;(2E)-N-Ethyl-N-(2-methylphenyl)-2-butenamide;2-Butenamide, N-ethyl-N-(2-methylphenyl)-component of Eurax;Crotalgin;Crotamitex;Eurasil;Eurax;Euraxil;n-ethyl-n-(2-methylphenyl)-2-butenamid;N-Ethyl-o-Crotonotoluidine (Crotamiton);Acetylcholine chloride;(2E)-N-ethyl-N-(2-methylphenyl)but-2-enamide;N-ethylcrotono-o-toluidide;N-Ethyl-o-crotonotoluidide,Crotamiton;N-Ethyl-N-(2-methylphenyl)-2-butenamide;N-ethyl-N-(o-tolyl)but-2-enamide;GTPL11165;HMS2097P04;Tox21_110446;Crotamiton (JAN/USP/INN);Bestloid;N-Crotonyl-N-ethyl-o-toluidine;HY-B1177;Crotamitonum [INN-Latin];SR-01000759366-6;BPBio1_001038;trans-N-Ethyl-N-(o-tolyl)-2-butenamide;HMS3714P04;G 7857;SBI-0206763.P001;2EEH27851Y;BRD-K57179821-001-05-5;Crotan;BRN 3275497;CS-4730;MLS002222307;A827519;NSC-78382;DTXCID4020664;Prestwick3_000951;NCGC00094571-04;SCHEMBL32934;Crotamitone;Tox21_300804;Crotamiton, United States Pharmacopeia (USP) Reference Standard;BSPBio_000942;Crotamiton, (E)-;EPA Pesticide Chemical Code 055701;SPECTRUM1505271;2-Butenamide, N-ethyl-N-(2-methylphenyl)-, (E)-;D01381;NSC758951;2-Butenamide, N-ethyl-N-(2-methylphenyl)-, (2E)-;UNII-2EEH27851Y;NSC-758951;s1711;AS-11641;Pharmakon1600-01505271;UNII-D6S4O4XD0H;Crotamiton, European Pharmacopoeia (EP) Reference Standard;NSC 758951;124236-29-9;EINECS 207-596-3;D70888;HMS2051E10;BCP13315;CHEMBL1200709;AB00513973_10;BRD-K57179821-001-08-9;N-Ethyl-o-crotonotoluidide; Crotamitone; Crotalgin; Eurasil; Euraxil;InChI=1/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3/b8-4;NCGC00094571-03;component of Eurax (Salt/Mix);CCG-39402;MLS001424003;SR-01000759366-4;o-CROTONOTOLUIDIDE, N-ETHYL-;BRD-K13240564-001-01-8;Crotonyl-N-ethyl-o-toluidine;MLS000759489;AB00513973-09;NCGC00254708-01;Caswell No. 431B;Q2439845;AKOS015892746;HMS1570P04;NCGC00094571-05;HMS2234E16;N-Ethyl-ortho-crotonotoluidide;DTXSID101256463;D6S4O4XD0H;2-Butenamide, N-ethyl-N-(2-methylphenyl)-;NCGC00016462-01;HMS2093O12;NC00107;Tox21_110446_1;AB00513973;NS00010892;(E)-N-ethyl-N-(2-methylphenyl)but-2-enamide;E0814;Q-200893;AI3-17732;Eurax (TN);N-Ethyl-o-crotonotoluidide, 97%;NSC78382;N-Ethyl-N-(2-methylphenyl)-2-butenamide #;NCGC00094571-08;SMR000059145;EN300-23049066;BSPBio_002722;(E)-crotamiton;HMS1922P21;NCGC00094571-01;Prestwick2_000951;(E)-N-Ethyl-N-(o-tolyl)but-2-enamide;(E)-N-ethyl-N-o-tolylbut-2-enamide;483-63-6;NCGC00094571-02;MLS002695895;trans-Crotamiton;MFCD00026989;SR-01000759366;CAS-483-63-6;Crotamiton, British Pharmacopoeia (BP) Reference Standard;HMS2090A10;Veteusan;3-12-00-01856 (Beilstein Handbook Reference);Crotamiton [USP:INN:BAN:JAN];N-ethyl-N-(2-methylphenyl)but-2-enamide;97%,predominantly tran... |
| CAS No. | 483-63-6 |
| 分子式 | C13H17NO |
| 分子量 | 203.28 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学